Collplant Biotechnologies Lt

Penny Stocks Biotech Stocks Healthcare Stocks

$0.80

+0.05 (+6.65%)

As of Feb 8, 2:29 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +2,049.0% upside

Low Target $14.35

Average Target $17.19

High Target $29.92

Current Price $0.80

Current
$0.80

Target
$17.19

$14.35 $17.19 avg $29.92

Scenario Analysis

Bear Case

$14.35

1,694.0%

Low target

Base Case

$17.19

+2,049.0%

Avg target

Bull Case

$29.92

+3,640.5%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$18.70

-95.7% from high

52-Week Low

$12.09

+-93.4% from low

Target vs 52W High

$17.19

-8.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%